초록 ▼

A family of selectively absorbable/biodegradable, fibrous composite constructs includes different combinations of biostable and absorbable/biodegradable yarns assembled as initially interdependent, load-bearing components, transitioning to exhibit independent functional properties during in vivo end

A family of selectively absorbable/biodegradable, fibrous composite constructs includes different combinations of biostable and absorbable/biodegradable yarns assembled as initially interdependent, load-bearing components, transitioning to exhibit independent functional properties during in vivo end-use. The family of constructs consists of two groups, one group is made of fiber-reinforced composites of high compliance, absorbable matrices of segmented polyaxial copolyesters reinforced with multifilament yarn constructs, which are combinations of ultrahigh molecular weight polyethylene fibers and at least one absorbable/biodegradable fiber selected from silk fibers and multifilament yarns made from linear segmented, l-lactide copolyesters and poly (3-hydroxyalkanoates, are useful in orthopedic, maxillofacial, urological, vascular, hernial repair and tissue engineering applications. The second group is made of coated and uncoated, warp-knitted mesh constructs for use in hernial, vascular, and urological tissue repair and tissue engineering.

대표청구항 ▼

1. An absorbable/biodegradable implant, fibrous composite construct comprising a fiber-reinforced matrix, the fiber-reinforced matrix comprising a biodegradable, segmented, polyaxial copolyester, the fiber-reinforced matrix comprising from about 10 percent to about 40 percent by weight of the absorb

1. An absorbable/biodegradable implant, fibrous composite construct comprising a fiber-reinforced matrix, the fiber-reinforced matrix comprising a biodegradable, segmented, polyaxial copolyester, the fiber-reinforced matrix comprising from about 10 percent to about 40 percent by weight of the absorbable/biodegradable implant, fibrous composite construct, the fiber-reinforced matrix further comprising i) a reinforcement comprising less than 40 percent by weight of at least one biostable yarn comprising a multifilament yarn of ultrahigh molecular weight polyethylene, wherein the biostable yarn of the reinforcement is surrounded by the fiber-reinforced matrix,ii) and at least one absorbable/biodegradable yarn comprising a heterochain polymer,wherein the at least one biostable yarn and the at least one absorbable/biodegradable yarn assembled as initially interdependent, load-bearing components, andwherein the biostable and biodegradable yarns transition during in vivo end-use to exhibit independent functional mechanical properties. 2. The absorbable/biodegradable, fibrous composite construct as in claim 1 wherein the biodegradable, segmented polyaxial copolyester of the matrix comprises an amorphous, polyaxial, polymeric initiator end-grafted with a mixture of ε-caprolactone and at least one cyclic monomer selected from the group consisting of l-lactide, dl-lactide, glycolide, and trimethylene carbonate, such that crystallizable terminal segments are formed. 3. The absorbable/biodegradable, fibrous composite construct as in claim 2 wherein the amorphous, polyaxial, polymeric initiator is formed by the ring-opening polymerization of trimethylene carbonate in the presence of a catalyst comprising stannous octanoate and a monocentric polyfunctional initiator selected from the group consisting of triethanolamine, trimethylolpropane, and pentaerythritol. 4. The absorbable/biodegradable, fibrous composite construct as in claim 2 wherein the amorphous, polymeric initiator is formed by the ring-opening polymerization of a mixture of trimethylene carbonate and at least one monomer selected from the group consisting of p-dioxanone, ε-caprolactone, and 1,5-dioxepan-2-one. 5. The absorbable/biodegradable, fibrous composite construct as in claim 1 wherein the biodegradable yarn comprises at least one polymer selected from the group consisting of silk protein, a linear, segmented l-lactide copolyester, and a poly(3-hydroxyalkanoate). 6. The absorbable/biodegrable, fibrous composite construct as in claim 5 wherein the biodegradable yarn comprises silk protein in the form of degummed, white Brazilian raw Bombyx mori silkworm fibers. 7. The absorbable/biodegradable, fibrous composite construct as in claim 5 wherein the biodegradable yarn comprises a segmented copolymer of l-lactide and at least one monomer selected from the group consisting of glycolide, ε-caprolactone, trimethylene carbonate, p-dioxanone, and a morpholinedione. 8. The absorbable/biodegradable, fibrous composite construct as in claim 5 wherein the biodegradable yarn comprises a poly(3-hydroxyalkanoate) selected from the group consisting of poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate). 9. The absorbable/biodegradable, fibrous composite construct as in claim 1 in the form of an orthopedic device. 10. The absorbable/biodegradable, fibrous composite construct as in claim 9 wherein the orthopedic device is selected from the group consisting of orthopedic sutures, orthopedic tapes, and orthopedic cords for attaching soft tissues to bone. 11. The absorbable/biodegradable, fibrous composite construct as in claim 9 wherein the orthopedic device is a scaffold for repairing ligaments and tendons. 12. The absorbable/biodegradable, fibrous composite construct as in claim 9 wherein the orthopedic device is a scaffold for tissue engineering ligaments, and tendons. 13. The absorbable/biodegradable, fibrous composite construct as in claim 1 the form of a tissue engineering scaffold for repairing or replacing maxillofacial tissues. 14. The absorbable/biodegradable, fibrous composite construct as in claim 1 in the form of a surgical mesh for repairing or tissue engineering of soft tissues. 15. The absorbable/biodegradable, fibrous composite construct as in claim 1 in the form of a hernial repair mesh and wherein the fibrous construct comprises a knitted construct. 16. The absorbable/biodegradable, fibrous composite construct as in claim 1 wherein the matrix further comprises at least one bioactive agent selected from the group consisting of agents, and tissue growth promoting agents. 17. The absorbable/biodegradable, fibrous composite construct as in claim 1 wherein the at least one biostable yarn comprises less than about 30 percent by weight of the construct. 18. The absorbable/biodegradable implant, fibrous composite construct as in claim 1 in the form of a warp-knitted mesh wherein the warp-knitted mesh is coated with 0.1 to 10 percent of an absorbable polyaxial polyester and wherein the polyester is made of at least two cyclic monomers selected from the group consisting of glycolide, l-lactide, trimethylene carbonate, ε-caprolactone and a morpholinedione. 19. The absorbable/biodegradable, fibrous composite construct as in claim 1 wherein the biostable yarn comprises at least one additional multifilament or monofilament yarn made from polymers selected from the group consisting of ultrahigh molecular weight polyethylene (UHMW-PE), polypropylene, an aliphatic polyamide, an aromatic polyamide, polyether-ether ketone, and a polyalkylene terephthalate, and wherein the absorbable/biodegradable yarn comprises at least one multifilament or monofilament yarn selected from the group consisting of silk, poly(3-hydroxyalkanoates), and poly(2-hydroxyalkanoates). 20. The absorbable/biodegradable, fibrous composite construct as in claim 18 wherein the biostable yarn comprises at least one additional multifilament or monofilament yarn made from polymers selected from the group consisting of ultrahigh molecular weight polyethylene (UHMW-PE), polypropylene, an aliphatic polyamide, an aromatic polyamide, polyether-ether ketone, and a polyalkylene terephthalate, and wherein the absorbable/biodegradable yarn comprises at least one multifilament or monofilament yarn selected from the group consisting of silk, poly(3-hydroxyalkanoates), and poly(2-hydroxyalkanoates). 21. The absorbable/biodegradable, fibrous composite construct as in claim 19 wherein the biostable yarn comprises a multifilament yarn of ultrahigh molecular weight polyethylene and the absorbable/biodegradable yarn comprises at least one multifilament yarn of a thermoplastic polymer selected from the group consisting of segmented linear copolyesters, segmented polyaxial copolyesters, and copolymers of 3-hydroxybutyrate. 22. The absorbable/biodegradable, fibrous composite construct as in claim 21 wherein the absorbable/biodegradable yarn comprises a copolyester having repeat units derived from at least two cyclic monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, and trimethylene carbonate. 23. The absorbable/biodegradable, fibrous composite construct as in claim 20 wherein the biostable yarn comprises a multifilament yarn of ultrahigh molecular weight polyethylene and the absorbable/biodegradable yarn comprises at least one multifilament yarn of a thermoplastic polymer selected from the group consisting of segmented linear copolyesters, segmented polyaxial copolyesters, and copolymers of 3-hydroxybutyrate. 24. The absorbable/biodegradable, fibrous composite construct as in claim 20 wherein the absorbable/biodegradable yarn comprises a copolyester having repeat units derived from at least two cyclic monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, and trimethylene carbonate. 25. The absorbable/biodegradable, fibrous composite construct as in claim 1 further comprising an additional biostable yarn comprising a polyethylene terephthalate multifilament yarn and the absorbable/biodegradable yarn comprises a multifilament yarn of a linear or polyaxial segmented copolyester containing repeat units derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, and trimethylene carbonate. 26. The absorbable/biodegradable, fibrous composite construct as in claim 1 further comprising an additional biostable yarn comprising a polypropylene monofilament or multifilament yarn and the absorbable/biodegradable yarn comprises a multifilament yarn of a linear or polyaxial segmented copolyester containing repeat units derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, and trimethylene carbonate. 27. The absorbable/biodegradable, fibrous composite construct as in claim 18 further comprising an additional_biostable yarn comprising a polyethylene terephthalate multifilament yarn and the absorbable/biodegradable yarn comprises a multifilament yarn of a linear or polyaxial segmented copolyester containing repeat units derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, and trimethylene carbonate. 28. The absorbable/biodegradable, fibrous composite construct as in claim 18 further comprising an additional biostable yarn comprising a polypropylene monofilament or multifilament yarn and the absorbable/biodegradable yarn comprises a multifilament yarn of a linear or polyaxial segmented copolyester containing repeat units derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, and trimethylene carbonate. 29. The absorbable/biodegradable, fibrous composite construct as in claim 18 wherein the absorbable coating further comprises at least one bioactive agent selected from the group consisting of anti-inflammatory agents, anesthetic agents, antineoplastic agents, antimicrobial agents, microbicidal agents, antithrombic agents, and cell growth-promoting agents. 30. A absorbable/biodegradable, composite warp-knitted mesh comprising: a fiber-reinforced interdependent, interlaced patterned mesh further comprising a biodegradable, segmented, polyaxial copolyester, the absorbable/biodegradable, composite warp-knitted mesh including a fiber reinforcement, i) the fiber reinforcement comprising less than 40 percent by weight of at least one biostable yarn comprising a multifilament yarn of ultrahigh molecular weight polyethylene and at least one absorbable/biodegradable yarn, andii) wherein the at least one absorbable/biodegradable yarn comprises a heterochain polymer,wherein the at least one biostable yarn and the at least one absorbable/biodegradable yarn assembled as initially interdependent, load-bearing components,wherein the biodegradable, segmented polyaxial copolyester and biostable yarn interlace to form a mesh that defines intersections and voids between the biodegradable, segmented polyaxial copolyester and biostable yarn, andwherein the biostable and biodegradable yarns transition during in vivo end-use to exhibit independent functional mechanical properties. 31. A absorbable/biodegradable, composite warp-knitted mesh as in claim 30 wherein the interdependent, interlaced pattern comprises from about 10 percent to about 40 percent by weight of the composite. 32. A absorbable/biodegradable, composite warp-knitted mesh as in claim 30 wherein the interdependent, interlaced pattern comprises from about 15 percent to about 50 percent by weight of the composite mesh. 33. A absorbable/biodegradable, composite warp-knitted mesh as in claim 30 wherein the biodegradable, segmented polyaxial copolyester of the interdependent, interlaced pattern comprises an amorphous, polyaxial, polymeric initiator end-grafted with a mixture of ε-caprolactone and at least one cyclic monomer selected from the group consisting of l-lactide, dl-lactide, glycolide, and trimethylene carbonate, such that crystallizable terminal segments are formed. 34. A absorbable/biodegradable, composite warp-knitted mesh as in claim 33 wherein the amorphous, polyaxial, polymeric initiator is formed by the ring-opening polymerization of trimethylene carbonate in the presence of a catalyst comprising stannous octanoate and a monocentric polyfunctional initiator selected from the group consisting of triethanolamine, trimethylolpropane, and pentaerythritol. 35. A absorbable/biodegradable, composite warp-knitted mesh as in claim 34 wherein the amorphous, polymeric initiator is formed by the ring-opening polymerization of a mixture of trimethylene carbonate and at least one monomer selected from the group consisting of p-dioxanone, ε-caprolactone, and 1,5-dioxepan-2-one.